Other
Journal
Recent Headlines
Wednesday, Jun 19
New Blood Test May Detect Colon Cancer Before It Develops
NIH Funds Industry Collaborations to Identify New Uses for Existing Compounds
Survey: Induction of Remission Influences Prescribing Decisions in RA
Safinamide Shows Promise as Add-On to Levodopa in Parkinson’s Patients
New Details About H7N9 Flu Infections
Tuesday, Jun 18
‘Watchful Waiting’ Is Safe, Cost-Saving in Low-Risk Prostate Cancer
FDA Agrees to Review Rizatriptan Oral Film Formulation for Acute Migraine
Feds Seek Broad Payment Options for Health Insurance Customers
Data Reviews Find Bone-Growth Product Has Limited Benefit, May Cause Harm
CDC Report: U.S. Adult Smoking Rate Dips to 18 Percent
Monday, Jun 17
Long-Term Data Support Safety Profile of Dabigatran (Pradaxa) for Stroke Prevention
New Guidelines for Management of Arterial Hypertension
Osteoporosis Therapy Stops Growth of Breast Cancer Cells
Phase III Trial Evaluates Novel Insulin Inhalation Powder for Type 2 Diabetes
NIH Launches Dietary Supplement Label Database
Friday, Jun 14
Study: Nervous System Plays Key Role in Arthritis
Alzheimer’s Drug Trial Halted Because of Liver Problems
Denosumab (Xgeva) Approved to Treat Bone Tumors
Supreme Court Rules ‘Naturally Occurring’ Human Genes Cannot Be Patented
FDA’s Cyber Security Team Issues Warning on Medical Devices
Thursday, Jun 13
‘Stewardship Program’ Helps Pediatricians Limit Misuse of Antibiotics
Report: Cancer Guidelines Do Not Fully Meet IOM Standards
Positive Phase III Results With Tocilizumab (RoACTEMRA) in Early RA
Study: Gene Variants May Predict Who Will Respond to Breast Cancer Prevention Drugs
Tenofovir (Viread) Halves HIV Risk in Intravenous Drug Users
Wednesday, Jun 12
Remote Patient Monitoring Seen as Way to Tackle Cuts in Health Care
Study: Blood Pressure at Night Is Higher Than Previously Thought
Abatacept (Orencia) and Adalimumab (Humira) Show Comparable Efficacy in RA Patients
Pilot Program Uses Telemedicine to Reduce Emergency Room Wait Times
Positive Phase III Results With Trebananib in Recurrent Ovarian Cancer
Tuesday, Jun 11
A Path to Lower-Risk Painkillers
Vegetable Fats May Reduce Mortality Risk in Prostate Cancer Patients
Tyrosine Kinase Inhibitor Lenvatinib Shows Promise in Melanoma Patients
Screening Fails to Affect Breast Cancer Mortality
Report: Medicare Spends Too Much on Brand-Name Diabetes Drugs
Monday, Jun 10
Extended-Release Amantadine (Nurelin) Shows Promise in Parkinson’s Disease
Report: Emerging Therapies Offer Efficacy Advantages Over Current Ovarian Cancer Treatments
Has Pancreatic Damage From Glucagon-Suppressing Diabetes Drugs Been Underplayed?
FDA Rejects Kidney Cancer Drug Tivozanib
Four-Strain Flu Vaccine Gets FDA Nod
Friday, Jun 7
Study: Breastfeeding Can Reduce Maternal Breast Cancer and Heart Disease
Triple Compound Shows Promise in Patients With Colorectal and Head-and-Neck Cancers
AHA Report: Small Lifestyle Changes May Have Big Impact on Reducing Stroke Risk
FDA Panel Votes to Relax Safety Restrictions on Rosiglitazone (Avandia)
Launch Set for Weight-Loss Drug Lorcaserin (Belviq)
Thursday, Jun 6
Autism Discovery Paves Way for Early Blood Test
NIH Scientists Discover How HIV Kills Immune Cells
Updated Guideline for Management of Heart Failure
FDA Approves Lenalidomide (Revlimid) for Mantle Cell Lymphoma
Report Highlights Emerging Role of Emergency Departments in U.S.
Wednesday, Jun 5
Revised Clinical Practice Guideline for Knee OA
Scientists Are ‘Itching’ to Help People Stop Scratching
New Data Show Fingolimod (Gilenya) Helps MS Patients
FDA Advisors Reconsider Safety of Diabetes Drug Rosiglitazone (Avandia)
Tuesday, Jun 4
Fluoroquinolone Antibiotics May Double Risk of Kidney Disease
States Could Lose $8.4 Billion Annually Without Medicaid Expansion, Study Finds
Smartphone Accessory Detects AIDS-Linked Cancer
Mixed Results Reported for Arthritis Drug Fostamatinib, Regulatory Filing Scrapped
CDC Report: Fewer Americans Having Problems Paying Medical Bills
Monday, Jun 3
Positive Phase III Results With Bevacizumab (Avastin) in Cervical Cancer
NIH Compares Diabetes Drugs in Head-to-Head Trial
Survey: Physicians See Adalimumab (Humira) as Best Option for Treating Psoriatic Arthritis
Breast Cancer Drug Lapatinib (Tykerb/Tyverb) Fails Gastric Cancer Study
Four Lifestyle Changes Protect the Heart, Reduce Risk of Death
Friday, May 31
Common NSAIDs May Increase Risk of Heart Attacks
Survey: Aubagio (Teriflunomide) Trails Gilenya (Fingolimod) for Multiple Sclerosis Treatment
FDA Rejects Testosterone Drug for Third Time
New Method to Test Breast Lesions Could Save Money
Double Dose of Tamiflu Offers No Added Benefit in Severe Influenza
